Nine Nations Agree to Build Synchrotron

LONDON—Europe has decided to remain at the forefront of condensed matter research with an agreement by nine countries to start building the $500 million European Synchrotron Radiation Facility (ESRF) next year in Grenoble, France. At the same time, the United Kingdom has bolstered its reputation for remaining out of step with the rest of European science by refusing to pledge its support for the ESRF at a key meeting last month. Although the British Science and Engineering Research Cou

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

LONDON—Europe has decided to remain at the forefront of condensed matter research with an agreement by nine countries to start building the $500 million European Synchrotron Radiation Facility (ESRF) next year in Grenoble, France.

At the same time, the United Kingdom has bolstered its reputation for remaining out of step with the rest of European science by refusing to pledge its support for the ESRF at a key meeting last month. Although the British Science and Engineering Research Council has helped to plan the new machine since it was proposed a decade ago, it cannot by itself raise sufficient funds to provide the 15 percent expected by its partners.

Ironically, Britain already operates the leading X-ray machine, SERC’s Synchrotron Radiation Source, at the Daresbury Laboratory in Cheshire. The machine has been upgraded recently to increase its brightness, and ESRF is regarded as its successor. The two will be complementary, with ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jon Turney

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio